331
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Oral bioavailability enhancement of flubendazole by developing nanofibrous solid dosage forms

, , , , , , , , , , , , , & show all
Pages 1126-1133 | Received 12 Aug 2016, Accepted 19 Feb 2017, Published online: 08 Mar 2017
 

Abstract

The bioavailability of the anthelminthic flubendazole was remarkably enhanced in comparison with the pure crystalline drug by developing completely amorphous electrospun nanofibres with a matrix consisting of hydroxypropyl-β-cyclodextrin and polyvinylpyrrolidone. The thus produced formulations can potentially be active against macrofilariae parasites causing tropical diseases, for example, river blindness and elephantiasis, which affect altogether more than a hundred million people worldwide. The bioavailability enhancement was based on the considerably improved dissolution. The release of a dose of 40 mg could be achieved within 15 min. Accordingly, administration of the nanofibrous system ensured an increased plasma concentration profile in rats in contrast to the practically non-absorbable crystalline flubendazole. Furthermore, easy-to-grind fibers could be developed, which enabled compression of easily administrable immediate release tablets.

Acknowledgements

A strong foundation of this work was the stimulating professional enthusiasm of Dr. Marcus E. Brewster, former Vice President and Scientific Fellow at Janssen Research and Development.

The authors are indebted to Éva Kiserdei for her outstanding technical support. This work is connected to the scientific program of the “Development of quality-oriented and harmonized R + D+ I strategy and functional model at BME” project. The authors mean to express their gratitude to Dr János Madarász (Budapest University of Technology and Economics, Hungary) for making XRD measurements possible in his laboratory.

Disclosure statement

The authors report no conflicts of interest.

Additional information

Funding

This project is supported by the New Széchenyi Plan (Project ID: TÁMOP-4.2.1/B-09/1/KMR-2010–0002), by OTKA research fund [grant number K112644], and by the János Bolyai Research Scholarship of the Hungarian Academy of Sciences.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.